WeGene

Shenzhen, China Founded: 2014 • Age: 12 yrs
Genetic testing is conducted using saliva for health risk detection.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About WeGene

WeGene is a company based in Shenzhen (China) founded in 2014. WeGene operates in a competitive market with competitors including CircleDNA, 23Mofang, GeseDNA, Aijiyin and 1JKT, among others.

  • Headquarter Shenzhen, China
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
    K2

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of WeGene

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2018 Amount Series B - WeGene Valuation

investors

Aug, 2015 Amount Seed - WeGene Valuation

investors

K2

Investors in WeGene

WeGene has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include K2, Huada Gene and Ameba Capital.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early and growth stage tech-focused VC firm investing primarily in China
Founded Year Domain Location
Genomics research and sequencing services are provided in China.
Founded Year Domain Location
Business process management platform provider
Founded Year Domain Location

Investments & Acquisitions by WeGene

Investments

Financial Statements - WeGene

Wegene Comparisons

+
Add Comparison
Available on Premium

Competitors of WeGene

WeGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CircleDNA, 23Mofang, GeseDNA, Aijiyin and 1JKT, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Internet-first platform for genetic diagnostics is provided.
domain founded_year HQ Location
Provides genetic testing services to help prevent potential problems and early intervention.
domain founded_year HQ Location
Gene detection tools and DNA interpretation services are provided.
domain founded_year HQ Location
Genetic testing solutions are offered via an online platform.
domain founded_year HQ Location
Online platform offering appointment booking services for genetic tests

Latest news on Wegene

Frequently Asked Questions about WeGene

WeGene was founded in 2014 and raised its 1st funding round 1 year after it was founded.

WeGene is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

WeGene was founded in 2014 in Shenzhen, China, within the genetic testing sector. Saliva-based tests are utilized to identify sources of health risks, including hereditary and complex diseases, as well as drug reactions. Characteristics are analyzed to support avoidance of such conditions. The service is priced at 999 yuan, with funding raised from K2 Ventures. Operations focus on direct-to-consumer genetic analysis.

WeGene's top competitors include CircleDNA, 23Mofang and GeseDNA.

WeGene has 3 investors. Key investors include K2, Huada Gene, and Ameba Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available